Asthma is a chronic respiratory disease,and clinically,asthma exacerbations remain difficult to treat.The disease is caused by combinations of and interactions between genetic and environmental factors.Genomic and gen...Asthma is a chronic respiratory disease,and clinically,asthma exacerbations remain difficult to treat.The disease is caused by combinations of and interactions between genetic and environmental factors.Genomic and genetic approaches identified many novel genes to treat asthma and brought new insights into the disease.The products of the genes have functional roles in regulating physiological or pathophysiological processes in airway structural cells and immune system cells.Genetic factors also interact with environmental factors such as air pollutants,and bacterial and viral infections to trigger the disease.Thymic stromal lymphopoietin(TSLP),orosomucoid-like 3(ORMDL3),and gasdermin B(GSDMB)are three genes identified by genetic studies to have a great potential as therapeutic targets of asthma.TSLP is an important driver of type 2 inflammation.ORMDL3 mediates cell stress,sphingolipid synthesis,and viral and bacterial infections.GSDMB regulates cell pyroptosis through its N and C terminals and can bind sulfatides to influence inflammatory response.Investigating inhibitors or modulators for these pathways would bring a new landscape for therapeutics of asthma in future.展开更多
哮喘是一种由遗传和环境因素共同影响的常见的气道慢性炎性疾病,其分子遗传学基础复杂多样,目前临床上仍无疗效显著的治疗方法.全基因组相关联研究通过寻找哮喘发病机制的基因靶点,从分子遗传学角度为儿童哮喘的精准化医疗提供新思路....哮喘是一种由遗传和环境因素共同影响的常见的气道慢性炎性疾病,其分子遗传学基础复杂多样,目前临床上仍无疗效显著的治疗方法.全基因组相关联研究通过寻找哮喘发病机制的基因靶点,从分子遗传学角度为儿童哮喘的精准化医疗提供新思路.现研究证明17q21位点上血清类黏蛋白1样蛋白3基因(ORMDL3)和gasdermin B (GSMDB)基因的表达影响儿童哮喘的易患性、严重性、及种族特异性.该文对17q21染色体位点上与儿童哮喘相关的基因进行综述.展开更多
文摘Asthma is a chronic respiratory disease,and clinically,asthma exacerbations remain difficult to treat.The disease is caused by combinations of and interactions between genetic and environmental factors.Genomic and genetic approaches identified many novel genes to treat asthma and brought new insights into the disease.The products of the genes have functional roles in regulating physiological or pathophysiological processes in airway structural cells and immune system cells.Genetic factors also interact with environmental factors such as air pollutants,and bacterial and viral infections to trigger the disease.Thymic stromal lymphopoietin(TSLP),orosomucoid-like 3(ORMDL3),and gasdermin B(GSDMB)are three genes identified by genetic studies to have a great potential as therapeutic targets of asthma.TSLP is an important driver of type 2 inflammation.ORMDL3 mediates cell stress,sphingolipid synthesis,and viral and bacterial infections.GSDMB regulates cell pyroptosis through its N and C terminals and can bind sulfatides to influence inflammatory response.Investigating inhibitors or modulators for these pathways would bring a new landscape for therapeutics of asthma in future.
基金国家自然科学基金青年基金(81500013)National Natural Science Foundation of China
文摘哮喘是一种由遗传和环境因素共同影响的常见的气道慢性炎性疾病,其分子遗传学基础复杂多样,目前临床上仍无疗效显著的治疗方法.全基因组相关联研究通过寻找哮喘发病机制的基因靶点,从分子遗传学角度为儿童哮喘的精准化医疗提供新思路.现研究证明17q21位点上血清类黏蛋白1样蛋白3基因(ORMDL3)和gasdermin B (GSMDB)基因的表达影响儿童哮喘的易患性、严重性、及种族特异性.该文对17q21染色体位点上与儿童哮喘相关的基因进行综述.